Veloxis Pharmaceuticals A/S - Veloxis Promotes John Weinberg to Chief ... Wall Street Journal Envarsus(R) is an investigational drug that is being developed as a once daily tablet version of tacrolimus, with improved bioavailability, consistent pharmacokinetic performance and reduced peak to trough variability when compared to currently ... |
